Former Food and Drug Administration (FDA) commissioner Scott Gottlieb has joined the board of the directors for health technology startup Aetion, Fierce Healthcare reports.
The company made the announcement Tuesday, Sept. 17.
“The widespread adoption of real-world evidence to the development and application of new treatments will improve the precision of prescribing decisions and help make drug discovery far more efficient,” Gottlieb said in a statement. “As a member of Aetion’s Board, I’m inspired by the opportunity to join the company’s efforts to bring RWE to the forefront of drug research and development.”
To read the full report, click here.
